Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dangerous interaction between the antibiotic ciprofloxacin and the muscle relaxant tizanidine

16.12.2004


Researchers from Finland have found that the antibiotic ciprofloxacin (brand names Ciproxin, Ciprofloxacin etc.) greatly increases the concentrations of tizanidine (Sirdalud, Zanaflex) in blood. Concomitant use of ciprofloxacin and tizanidine results in severe and prolonged decrease in blood pressure and greatly enhances central nervous system effects.



This previously unrecognised interaction can be dangerous, particularly in elderly patients, and the concomitant use of the two agents must be avoided. Tizanidine is widely used for treatment of musculoskeletal pain associated with increased muscle tension or chronic spasticity.

The concentrations of tizanidine in blood were increased on average 10-fold by ciprofloxacin in a carefully controlled study in healthy volunteer subjects. The volunteers ingested the usual 500-mg dose of ciprofloxacin (or placebo) twice daily for 3 days, and then a single 4-mg dose of tizanidine. The interaction was observed in each of the ten subjects; the greatest increase in tizanidine concentration by ciprofloxacin was 24-fold.


Ciprofloxacin enhanced greatly also the effects of tizanidine. In particular, the decrease in systolic (“upper”) blood pressure, to the level of 90-mm Hg or even less, was an alarming finding. Such hypotension can be dangerous, eg in elderly subjects and in patients who have heart problems. Also the central nervous system effects of tizanidine were greatly enhanced by ciprofloxacin: all ten subjects were somnolent and dizzy for about 3 hours after tizanidine intake.

Both tizanidine and ciprofloxacin are widely used drugs in many countries. E.g. in Finland (population 5 200 000) about 136 000 patients used tizanidine and about 60 000 patients used ciprofloxacin during the year 2003. Therefore, it is likely that ciprofloxacin and tizanidine can be coadministrered, if the risk of the interaction is not recognised by clinicians.

The interaction results from inhibition of the liver metabolism of tizanidine by ciprofloxacin. The same mechanism causes a serious interaction also between the antidepressant fluvoxamine and tizanidine, which was uncovered earlier this year. Further studies are being carried out to study whether there are other unrecognised interactions between tizanidine and other drugs.

The study was conducted at the Department of Clinical Pharmacology, University of Helsinki, by an independent group of researchers led by Professor Pertti J Neuvonen, MD, PhD, and Dr. Janne T Backman, MD, PhD. The study was published in the December issue of Clinical Pharmacology & Therapeutics, the leading scientific journal within the clinical pharmacology and therapeutics area.

Paivi Lehtinen | alfa
Further information:
http://www.helsinki.fi

More articles from Life Sciences:

nachricht Multifunctional nano-sized drug carriers based on reactive polypept(o)ides
13.09.2017 | Johannes Gutenberg-Universität Mainz

nachricht Supported liquid metal catalysts – a new generation of reaction accelerators
13.09.2017 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

Im Focus: Using Mirrors to Improve the Quality of Light Particles

Scientists from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute have succeeded in dramatically improving the quality of individual photons generated by a quantum system. The scientists have successfully put a 10-year-old theoretical prediction into practice. With their paper, published recently in Physical Review X, they have taken an important step towards future applications in quantum information technology.

For a number of years, scientists have been working on using electron spins to store and process information. A possible approach is to use a quantum system in...

Im Focus: High-speed Quantum Memory for Photons

Physicists from the University of Basel have developed a memory that can store photons. These quantum particles travel at the speed of light and are thus suitable for high-speed data transfer. The researchers were able to store them in an atomic vapor and read them out again later without altering their quantum mechanical properties too much. This memory technology is simple and fast and it could find application in a future quantum Internet. The journal Physical Review Letters has published the results.

Even today, fast data transfer in telecommunication networks employs short light pulses. Ultra broadband technology uses optical fiber links through which...

Im Focus: Discovery of the most accelerated binary pulsar

Fifty years after Jocelyn Bell discovered the first pulsar, students are no longer going through reams of paper from pen chart recorders but instead search through 1,000s of terabytes of data to find these enigmatic pulsating radio stars. The most extreme binary pulsar system so far, with accelerations of up to 70 g has been discovered by researchers at the Max Planck Institute for Radio Astronomy (MPIfR) in Bonn. At their closest approach the orbit of the pulsar and its companion neutron star would easily fit inside the radius of the Sun.

Although most of the more than 2,500 pulsars known are solitary objects, a few are found in tight binary systems. The discovery of the first of these, the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

IVAM’s LaserForum visits the Swiss canton of St. Gallen with the topic ultrashort pulse lasers

06.09.2017 | Event News

 
Latest News

Supported liquid metal catalysts – a new generation of reaction accelerators

13.09.2017 | Life Sciences

Multifunctional nano-sized drug carriers based on reactive polypept(o)ides

13.09.2017 | Life Sciences

Radioactive Metal Complexes for Tumour Diagnosis and Therapy

12.09.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>